Lupus anticoagulant-hypoprothrombinemia syndrome and similar diseases: experiences at a single center in Japan

[1]  P. Cortesi,et al.  Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data. , 2017, Blood advances.

[2]  J. Zehnder,et al.  Prozone Effect in the Diagnosis of Lupus Anticoagulant for the Lupus Anticoagulant-Hypoprothrombinemia Syndrome. , 2016, American journal of clinical pathology.

[3]  E. Morales,et al.  Síndrome de anticoagulante lúpico-hipoprotrombinemia: una extraña asociación en el lupus eritematoso sistémico , 2016 .

[4]  F. Keyser,et al.  Lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature , 2015, Lupus.

[5]  M. Shima,et al.  Lupus anticoagulant hypoprothrombinemia syndrome in Bence-Jones protein κ-type multiple myeloma patient with phosphatidylserine-dependent antiprothrombin antibody , 2012, Annals of Hematology.

[6]  J. Piette,et al.  Lupus Anticoagulant-Hypoprothrombinemia Syndrome: Report of 8 Cases and Review of the Literature , 2012, Medicine.

[7]  G. Rodgers,et al.  Laboratory identification of lupus anticoagulants , 2009, American journal of hematology.

[8]  Chiyoung Park,et al.  Lupus anticoagulant-hypoprothrombinemia in healthy adult , 2008, The Korean journal of internal medicine.

[9]  Y. Shoenfeld,et al.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.

[10]  S. Iliceto,et al.  Antibody profiles for the diagnosis of antiphospholipid syndrome , 2005, Thrombosis and Haemostasis.

[11]  U. Jaeger,et al.  Transient lupus anticoagulant associated with hypoprothrombinemia and Factor XII deficiency following adenovirus infection , 1993, Annals of Hematology.

[12]  P. D. de Groot,et al.  beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. , 2004, Blood.

[13]  A. Tsutsumi,et al.  Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. , 2000, Arthritis and rheumatism.

[14]  A. Kaider,et al.  Clinical significance of lupus anticoagulants in children. , 1999, The Journal of pediatrics.

[15]  C. Male.  Clinical signification of lupus anticoagulant in children , 1999 .

[16]  I. Scharrer,et al.  Criteria for the Diagnosis of Lupus Anticoagulants: An Update , 1995, Thrombosis and Haemostasis.

[17]  M. van den Berg,et al.  The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliability , 1995, Thrombosis and Haemostasis.

[18]  T. Sumida,et al.  Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. , 1992, Journal of immunology.

[19]  D. Simel,et al.  Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus anticoagulant-hypoprothrombinemia syndrome. , 1987, The American journal of medicine.

[20]  G. Hughes,et al.  Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. , 1987, Clinical and experimental immunology.

[21]  Y. Et,et al.  Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus. , 1965 .

[22]  L. Gaston,et al.  Purification and Kinetic Studies on a Circulating Anticoagulant in a Suspected Case of Lupus Erythematosus* , 1965, Thrombosis and Haemostasis.

[23]  S. Rapaport,et al.  A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with antiprothrombinase activity. , 1960, Blood.